These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7715472)

  • 1. Endometrial hyperplasia: efficacy of a new treatment with a vaginal cream containing natural micronized progesterone.
    Affinito P; Di Carlo C; Di Mauro P; Napolitano V; Nappi C
    Maturitas; 1994 Dec; 20(2-3):191-8. PubMed ID: 7715472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of simple and complex endometrial non-atypical hyperplasia with natural progesterone: response rate to different doses.
    Marra C; Penati C; Ferrari L; Cantù MG; Bargossi L; Fruscio R
    Gynecol Endocrinol; 2014; 30(12):899-901. PubMed ID: 25111756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficacy of micronized progesterone and lynestrenol in treatment of simple endometrial hyperplasia without atypia.
    Tasci Y; Polat OG; Ozdogan S; Karcaaltincaba D; Seckin L; Erkaya S
    Arch Gynecol Obstet; 2014 Jul; 290(1):83-6. PubMed ID: 24488582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study on the effect of vaginal administration of micronized progesterone at dysfunctional uterine bleeding in premenopause].
    Kostova P; Zlatkov V
    Akush Ginekol (Sofiia); 2009; 48(2):3-7. PubMed ID: 20198768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial response to a cyclic regimen of percutaneous 17beta-estradiol and low-dose vaginal micronized progesterone in women with mild-to-moderate hypertension.
    Vilodre LC; Osório Wender MC; Sisson de Castro JA; dos Reis FM; Ruschel S; Magalhães JA; Spritzer PM
    Gynecol Endocrinol; 2003 Aug; 17(4):323-8. PubMed ID: 14503977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal endometrial hyperplasia: role of danazol therapy.
    Mariani L; Sedati A; Giovinazzi R; Sindico R; Atlante G
    Int J Gynaecol Obstet; 1994 Feb; 44(2):155-9. PubMed ID: 7911101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Efficacy of Dienogest in the Treatment of Simple Endometrial Hyperplasia without Atypia.
    Uysal G; Acmaz G; Madendag Y; Cagli F; Akkaya H; Madendag I; Karakilic EU
    Gynecol Obstet Invest; 2018; 83(2):151-155. PubMed ID: 28715800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of long-term use of progesterone therapy on proliferation and apoptosis in simple endometrial hyperplasia without atypia.
    Bese T; Vural A; Ozturk M; Dagistanli F; Demirkiran F; Tuncdemir M; Arvas M; Sanioglu C; Kosebay D
    Int J Gynecol Cancer; 2006; 16(2):809-13. PubMed ID: 16681766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on endometrial histology and pharmacokinetics of different dose regimens of progesterone vaginal pessaries, in comparison with progesterone vaginal gel and placebo.
    Duijkers IJM; Klingmann I; Prinz R; Wargenau M; Hrafnsdottir S; Magnusdottir TB; Klipping C
    Hum Reprod; 2018 Nov; 33(11):2131-2140. PubMed ID: 30265306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letrozole as primary therapy for endometrial hyperplasia in young women.
    Li HZ; Chen XN; Qiao J
    Int J Gynaecol Obstet; 2008 Jan; 100(1):10-2. PubMed ID: 17889878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial response to concurrent treatment with vaginal progesterone and transdermal estradiol.
    Fernández-Murga L; Hermenegildo C; Tarín JJ; García-Pérez MÁ; Cano A
    Climacteric; 2012 Oct; 15(5):455-9. PubMed ID: 22321028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A "no-bleeding" substitute hormone treatment with an oral microdose progesterone. A prospective multicenter study].
    Gillet JY; Faguer B; André G; Magnin G; de Lignières B; Philippe E
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(4):407-12. PubMed ID: 8051369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of micronized progesterone on the endometrium: a systematic review.
    Stute P; Neulen J; Wildt L
    Climacteric; 2016 Aug; 19(4):316-28. PubMed ID: 27277331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal estradiol and oral or vaginal natural progesterone: bleeding patterns.
    Di Carlo C; Tommaselli GA; Gargano V; Savoia F; Bifulco G; Nappi C
    Climacteric; 2010 Oct; 13(5):442-6. PubMed ID: 20575654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept.
    Fatemi HM; Bourgain C; Donoso P; Blockeel C; Papanikolaou EG; Popovic-Todorovic B; Devroey P
    Hum Reprod; 2007 May; 22(5):1260-3. PubMed ID: 17227809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of premenopausal endometrial hyperplasia by a combination of a long-acting estrogen and a cyclic progestogen.
    Ricciardi I; Bertorello G; Bruni G; Cali A; Imparato E; Sallusto A
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):402-16. PubMed ID: 4198302
    [No Abstract]   [Full Text] [Related]  

  • 18. [The role of gestagens in prevention and therapy of endometrial hyperplasia].
    Römer T
    Zentralbl Gynakol; 1995; 117 Suppl():14-8. PubMed ID: 8571687
    [No Abstract]   [Full Text] [Related]  

  • 19. Levonorgestrel-releasing intrauterine device versus dydrogesterone for management of endometrial hyperplasia without atypia.
    El Behery MM; Saleh HS; Ibrahiem MA; Kamal EM; Kassem GA; Mohamed Mel S
    Reprod Sci; 2015 Mar; 22(3):329-34. PubMed ID: 25001020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome.
    Cheung AP
    Obstet Gynecol; 2001 Aug; 98(2):325-31. PubMed ID: 11506853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.